Back
AbCellera Biologics Vs. Aurinia Pharmaceuticals Industry Stock Comparison
Sell
49
ABCL
AbCellera Biologics
Last Price:
3.65
Seasonality Move:
15.3%
Sell
50
AUPH
Aurinia Pharmaceuticals
Last Price:
5.74
Seasonality Move:
0.65%
Sell
49
AbCellera Biologics (ABCL)
is a Sell
Is AbCellera Biologics a Buy, Sell or Hold?
- The current AbCellera Biologics [ABCL] share price is $3.78. The Score for ABCL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- ABCL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.77. The Score for AUPH is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABCL Stock Price Chart
What is AbCellera Biologics's stock price today?
-
The AbCellera Biologics share price today is $3.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing slight buying pressure.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
ABCL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 41.64 | Sell |
| Chaikin Money Flow: | 327883 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.75 - 4.07) | Sell |
| Bollinger Bands (100): | (4.14 - 5.42) | Sell |
AUPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.05 | Buy |
| Relative Strength Index (14 RSI): | 70.09 | Buy |
| Chaikin Money Flow: | 2418307 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.91 - 5.27) | Buy |
| Bollinger Bands (100): | (4.85 - 7.81) | Sell |
ABCL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.85 | Sell |
| 20-day SMA: | 3.87 | Sell |
| 50-day SMA: | 4.25 | Sell |
| 200-day SMA: | 4.85 | Sell |
| 8-day EMA: | 3.83 | Sell |
| 20-day EMA: | 3.92 | Sell |
| 50-day EMA: | 4.21 | Sell |
| 200-day EMA: | 5.17 | Sell |
AUPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.22 | Buy |
| 20-day SMA: | 5.12 | Buy |
| 50-day SMA: | 5.11 | Buy |
| 200-day SMA: | 7.46 | Sell |
| 8-day EMA: | 5.29 | Buy |
| 20-day EMA: | 5.18 | Buy |
| 50-day EMA: | 5.4 | Buy |
| 200-day EMA: | 7.08 | Sell |
AbCellera Biologics Earnings Growth & ABCL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.08 per share.
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
AbCellera Biologics Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Aurinia Pharmaceuticals Technical Analysis
| May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||